For all invasive carcinomas (B5), our reporting system follows the recommendation of the College of American Pathologists breast invasive biopsy cancer protocol which includes essential components such as grade, histological subtype, and assessment of prognostic and predictive factors such as Ki67, ER, and HER2 assessment. This evidence concerns the gene MKI67 and cancer.